🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Switching from sema to tirz and WOW the difference Page 5

Switching from sema to tirz and WOW the difference

KarenAZ_mom Wed, Apr 1, 2026 at 8:41 AM 27 replies 1,036 viewsPage 5 of 6
anna.melb_AU
Member
678
2,890
Apr 2024
Melbourne, AU
Apr 16, 2026 at 9:30 PM#21
wendy_avl said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Genuinely useful, thank you. I had the facts and not the framework. Printing the relevant bit and taking it with me.

11 11DerekSJ_a1c, paige_pharma, emma_london and 8 others
Reply Quote Save Share Report
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Apr 22, 2026 at 4:40 AM#22

From the other side of the consultation, briefly. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Ask again with the specifics and you will get a better answer than this one.

10 10mike_mod, SarahChen_PharmD, sarah.morrison and 7 others
Reply Quote Save Share Report
FranDenver
Member
267
1,123
Oct 2024
Denver, CO
Apr 27, 2026 at 11:48 AM#23
TinaHashiRN said:
It helps to say which part of this you are uncertain about.

Mine went the same way, slower. I had assumed I was the exception until I read this.

9 9BariatricNurseD, MASHdoc_SA, GenomicsKate and 6 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
May 2, 2026 at 6:52 PM#24
TinaHashiRN said:
It helps to say which part of this you are uncertain about.

Coming at TinaHashiRN’s question from a different direction. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

8 8oliver_london, tane_welly, Dr.PathRoch and 5 others
Reply Quote Save Share Report
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
May 8, 2026 at 1:53 AM#25

Adding the numbers, since they settle part of this. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

7 7jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 4 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register